European Innovation Council

Chipiron is a developer of advanced portable MRI machines that utilize cutting-edge quantum detectors to generate high-resolution three-dimensional anatomical images. By operating at ultra-low magnetic fields, these machines are designed to be lightweight and cost-effective, significantly reducing the price compared to traditional MRI systems. Chipiron's technology aims to enhance disease detection, diagnosis, and treatment monitoring, particularly for brain-related conditions, thereby assisting healthcare institutions in improving patient outcomes and potentially decreasing fatality rates associated with these ailments.

Astrape powers the future of datacenters: more bandwidth, less power.

VSORA is an intellectual property provider based in France, specializing in digital signal processing (DSP) technology for semiconductor chips used in advanced digital communications systems, including 5G networks. Founded in 2015 by a team of experienced DSP engineers, the company offers a powerful multi-core DSP architecture that eliminates the need for DSP co-processors, allowing for greater flexibility akin to software programming. VSORA's innovative DSP development flow facilitates collaboration between signal processing and software engineers, significantly accelerating time-to-market for new products. The company focuses on enhancing DSP computing power while optimizing power consumption and performance, ultimately reducing the silicon footprint required for complex integrated circuits.

AMT Medical B.V., established in 2015 and located in Ede, the Netherlands, specializes in the development of innovative medical devices for heart bypass surgery. The company's flagship product, the AMT Heart Bypass System, utilizes a minimal invasive technique known as the ELANA bypass, which was invented by neurosurgeon Prof. Dr. C.A.F. Tulleken and his research team. This advanced technology aims to enhance traditional heart bypass procedures by making them faster, safer, and less invasive, thereby improving patient outcomes and reducing complications. AMT Medical has completed the full development of its product and the production process, with all pre-clinical trials successfully concluded. The company is also preparing to initiate a clinical multi-center trial to further validate the technology's efficacy.

Sparrow Quantum Aps. is a Danish company focused on advancing quantum technology through the development of light-matter interfaces. It specializes in creating deterministic single-photon sources, which are essential for various quantum applications. The company boasts the highest efficiency in on-chip single-photon sources globally, characterized by superior photon purity, indistinguishability, and outcoupling capabilities. This innovative technology is the culmination of over twenty years of research at the renowned Niels Bohr Institute in Copenhagen, from which Sparrow Quantum holds exclusive licenses to key patents. By leveraging self-assembled quantum dots integrated with slow-light photonic-crystal waveguides, Sparrow Quantum enhances light-matter interaction, providing clients with advanced solutions for their quantum technology needs.

FaradaIC Sensors focuses on developing miniaturized gas sensors aimed at enhancing dioxygen detection capabilities for electronic devices. By employing standard microfabrication techniques, the company effectively reduces both the size and power consumption of its sensors, leading to lower production costs. This innovative approach allows for the commoditization of gas sensors, making them accessible and affordable for a variety of Internet of Things applications. FaradaIC Sensors is positioned to capitalize on the growing demand for flexible and cost-effective gas sensing solutions in the expanding IoT market.

BlueHeart Energy is a deep tech company focused on developing innovative green technologies to enhance heat pump performance. Utilizing thermoacoustics, the company generates sound waves within a closed circuit to produce heat and cold, marking a significant advancement as this technology is now being applied to residential heat pumps, previously limited to industrial applications. BlueHeart's products are designed to replace critical components in heat pumps, facilitating easy integration for original equipment manufacturers. The resulting heat pumps are versatile, silent, and cost-effective, suitable for both new and existing homes. Additionally, BlueHeart's technology is environmentally friendly, producing no CO2 emissions and eliminating the need for refrigerants, thus contributing to sustainable heating and cooling solutions.

Marvel Fusion is a Munich-based company established in 2019 that specializes in the development of fusion energy technology. The company focuses on creating a laser-based nuclear fusion reactor designed to provide environmentally friendly and safe energy solutions. Its innovative reactor utilizes short pulse, high energy, and electrically efficient lasers, making it suitable for the commercialization of baseload fusion electrical power. By advancing this technology, Marvel Fusion aims to enable consumers to access clean, reliable energy sources, contributing to a sustainable energy future.

Brevel is a company that specializes in innovative cultivation technology for microalgae, aimed at producing sustainable and high-quality products for various emerging markets. Utilizing advanced indoor systems that are sterile and fully automated, Brevel's method employs high-intensity internal illumination, resulting in significant cost reductions of over 90% and yield increases of up to 200 times compared to traditional methods. This breakthrough technology positions Brevel to capitalize on the growing demand for microalgae-derived products in sectors such as food, materials, chemicals, pharmaceuticals, and energy, providing an alternative protein source suitable for mass production.

QuantWare is a leading provider of quantum hardware, specializing in the development of scalable quantum processors. The company is known for its VIO QPU scaling technology, which supports the Quantum Open Architecture paradigm and facilitates the rapid advancement of quantum computing capabilities. With a focus on a 3D-dimensional chip architecture, QuantWare offers fully packaged quantum processing units (QPUs) and various Foundry and Packaging Services. This technology enables customers across 20 countries to build scalable quantum computers that can address complex real-world challenges in fields such as climate science and life sciences. By providing a robust platform for qubit design, QuantWare aims to unlock the potential for systems exceeding one million qubits, making significant strides in the quantum computing landscape.

Skyfora is a company focused on enhancing weather observation and forecasting capabilities through innovative technology. It addresses the limitations of traditional weather data by utilizing repurposed GNSS receivers located in telecom base stations, transforming them into advanced 4D weather scanners. This approach generates significantly more weather observation data, improving the accuracy and performance of AI-driven weather forecasts. Additionally, Skyfora develops forecasting software that leverages computer vision and IoT technologies to analyze high-resolution satellite images, particularly for predicting hurricanes. This technology aids disaster management efforts by providing critical insights that can help mitigate the impacts of severe weather events. Through its advancements, Skyfora contributes to global sustainability and enhances the operational efficiency of industries reliant on accurate weather information.

PrecisionLife is a company focused on advancing precision medicine by leveraging its proprietary artificial intelligence platform to enhance the understanding of chronic diseases. It specializes in patient stratification, which allows for the identification of novel subgroups within patient populations, thereby generating insights that inform the discovery of new drug targets and drug repositioning candidates. By utilizing unique and patentable biomarkers, PrecisionLife connects patients with specific disease sub-groups and potential therapies, ultimately aiming to create personalized treatment alternatives. The company’s innovative approach not only drives advancements in biopharmaceuticals but also seeks to improve patient outcomes, enabling individuals to lead longer and healthier lives.

Wooptix S.L., founded in 2014 and headquartered in Madrid, Spain, specializes in developing advanced imaging technologies. The company focuses on light field and wavefront phase imaging software that captures comprehensive information about light, utilizing the full resolution of sensors. Wooptix's platform enables the three-dimensional modulation of images, allowing for higher data points at elevated frame rates in volumetric images and videos. This technology facilitates enhanced image quality and advanced post-processing capabilities, providing users with innovative ways to interact with and visualize their environments. Wooptix aims to improve human experiences through its cutting-edge imaging solutions.

Stablepharma Ltd is a biotechnology company based in Bath, United Kingdom, focused on developing innovative processes for vaccine stabilization. Its technology platform, StablevaX™, transforms existing approved vaccines, therapeutics, and diagnostics into thermostable products that do not require refrigeration, addressing significant challenges in cold chain logistics. By enabling pre-dosed and stable vaccine delivery, Stablepharma aims to eliminate waste and reduce costs in the distribution of medical products. The company has identified up to 60 vaccine candidates suitable for its technology and collaborates actively with global vaccine manufacturers, academic institutions, and non-governmental organizations to advance its pipeline of thermostable solutions. Established in 2012, Stablepharma is dedicated to improving access to vaccines for children and adults, while also contributing to reduced carbon dioxide emissions in the healthcare sector.

MOA make healthy food for a sustainable world that solves growing global food demands. They are establishing a new industry of sustainable food that solves growing global food demands without the need for arable land. They are focused on designing high-value, natural and nutritious food.

MOA make healthy food for a sustainable world that solves growing global food demands. They are establishing a new industry of sustainable food that solves growing global food demands without the need for arable land. They are focused on designing high-value, natural and nutritious food.

Deeploy is a developer of a machine learning operations platform that focuses on making artificial intelligence explainable, trustworthy, and accountable. The company's platform centralizes explainable AI within machine learning operations, enhancing the accountability of AI systems. By providing tools for organizing deployments, addressing model degradation, generating trace logs, and creating custom models and explainers, Deeploy empowers data scientists and users to comprehend the functionality and implications of machine learning models. This capability allows for informed corrections of automated decisions, ensuring that AI systems operate transparently and responsibly.

ATMOS Space Cargo specializes in the development and manufacturing of space capsules designed to facilitate the return of cargo from space. The company's offerings include return capsules and atmospheric decelerators, which enable microgravity experiments and the transport of commercial products. These technologies allow clients to conduct life sciences research in a microgravity environment, addressing various challenges associated with such studies. By providing microgravity on demand, ATMOS Space Cargo supports a range of applications, enhancing the capabilities of researchers and commercial entities in the space industry.

QDI Systems B.V. is a startup based in Groningen, the Netherlands, focused on developing advanced imaging devices for medical applications using quantum dot technology. The company specializes in creating X-ray sensors that deliver high-contrast and high-resolution imaging, particularly for mammography, while also reducing radiation exposure for patients. QDI Systems aims to provide user-friendly quantum dot materials accompanied by comprehensive instructions for constructing high-performance imaging devices. By leveraging innovative technology, the company enhances the precision of medical imaging, enabling healthcare professionals to obtain critical diagnostic information efficiently and safely.

AlzeCure Pharma AB is a pharmaceutical company based in Huddinge, Sweden, that specializes in developing drug therapies aimed at treating diseases affecting the central nervous system, with a particular emphasis on Alzheimer's disease. Established in 2012, the company is advancing multiple drug candidates through its research platforms, NeuroRestore and Alzstatin, among others. Current projects include ACD855, which is undergoing Phase I clinical trials for sleep disruptions, traumatic brain injuries, and Alzheimer's disease, along with several other candidates targeting Alzheimer's: ACD856, ACD679, and ACD680. Additionally, AlzeCure is developing ACD857 for eye and ear conditions, and VR1 for neuropathic pain, alongside TrkA-NAM for osteoarthritic pain. Through its focused research initiatives, AlzeCure Pharma aims to address significant unmet medical needs in neurodegenerative diseases.

QDI Systems B.V. is a startup based in Groningen, the Netherlands, focused on developing advanced imaging devices for medical applications using quantum dot technology. The company specializes in creating X-ray sensors that deliver high-contrast and high-resolution imaging, particularly for mammography, while also reducing radiation exposure for patients. QDI Systems aims to provide user-friendly quantum dot materials accompanied by comprehensive instructions for constructing high-performance imaging devices. By leveraging innovative technology, the company enhances the precision of medical imaging, enabling healthcare professionals to obtain critical diagnostic information efficiently and safely.

Elicera Therapeutics is a clinical-stage immuno-oncology company based in Sweden that focuses on developing innovative cell and gene therapies to treat cancer. The company’s portfolio includes four drug candidates: two oncolytic virus therapies, ELC-100 and ELC-201, and two CAR T-cell treatments, ELC-301 and ELC-401. Additionally, Elicera has developed a universal CAR T-cell technology platform named iTANK (ELC-001), designed to enhance the efficacy of CAR T-cell therapies by enabling a multi-targeted approach against solid tumors. With its commitment to advancing immune-based cancer treatments, Elicera Therapeutics aims to improve outcomes for patients facing various forms of cancer.

Aplagon is a biopharmaceutical company focused on the development of innovative antithrombotic compounds aimed at addressing unmet medical needs in patients experiencing complications from vascular interventions. The company specializes in creating biological mimetics of heparin proteoglycan, which are designed to effectively manage thrombotic occlusions and ischemic reperfusion injuries associated with vascular injuries. By prioritizing safety and efficacy, Aplagon seeks to deliver antithrombotic therapies that offer significant advantages over existing treatments, ultimately improving patient outcomes in challenging medical scenarios.

TENSIVE s.r.l. is a biomedical company based in Milan, Italy, founded in 2012. It specializes in the development of innovative prostheses for natural breast reconstruction and augmentation. The company's products utilize biodegradable synthetic biomaterials and feature an internal micro-architecture that mimics blood vessel structures. These vascularized prostheses aim to enhance the quality of life for patients undergoing treatment for breast cancer, offering a solution that reduces the need for recurrent and costly surgical interventions. Through its focus on advanced biomaterials and design, TENSIVE seeks to provide effective and sustainable options for breast reconstruction.

Alcyon Photonics specializes in the design and development of integrated photonic devices, focusing on products that facilitate the creation, manipulation, and detection of light. Their offerings include photonic IP building blocks and platforms for managing and commercializing photonic integrated circuits (PICs). Utilizing a unique approach based on subwavelength grating, Alcyon Photonics enables advanced light management through a metamaterial-like design. This innovative technology supports smooth integration with circuit layout tools and commercial process design kits (PDKs), enhancing compatibility with foundries and simulation software. Their devices are applicable across various fields, including optical communications, biochemical sensing, and spectrometry, particularly in the context of microsatellites. Through their designs, Alcyon Photonics aims to empower customers to enhance their element designs and develop circuits based on specific functionalities.

Dotlumen is a research startup founded in 2020 and based in Cluj, Romania, focused on enhancing the quality of life for visually impaired individuals. The company develops innovative glasses equipped with a sensory and feedback system that aids users in navigating their environments. By leveraging advancements in artificial intelligence, robotics, and neuroscience, Dotlumen aims to empower blind individuals to better understand and interact with the world around them.

Photon IP is a deeptech startup located in Eindhoven, the Netherlands, specializing in the development of advanced technologies for photonics applications. The company focuses on creating application-specific semiconductors that cater to various industries, including automotive and telecommunications. Its innovative products are designed to enhance the production of wearable electronics and improve data center operations, providing tailored solutions that address the evolving needs of its clients.

AQLAS is shaping the quantum future and discovering Next-Gen Lasers redefining quantum computing. Our high-quality hardware is set apart by its economical, compact, and efficient nature, thus paving the way for the proliferation of quantum computers.

Patient-specific right heart pumps that free patients from heavy battery packages and increase patient's quality of life.

Hervolution Therapeutics focuses on developing first-in-class immunotherapies to combat tumors from within. The company leverages Human Endogenous Retroviral proteins (HERVs) to create rationally designed immune therapeutics targeting the dark genome. Hervolution Therapeutics aims to address hidden enemies within the human body by pioneering innovative biotechnology solutions.

ION-X is a technology company focused on developing advanced propulsion systems for small spacecraft. It specializes in electric propulsion technologies that utilize the ejection of fully ionized particles, offering high thrust and specific impulse (ISP). The company's innovative approach ensures long operational life and high modularity, making its solutions adaptable for various applications in the aerospace market. Additionally, ION-X aims to provide competitive production costs, facilitating mass production and meeting the increasing demand for efficient thrusters in the satellite industry.

GBM Works B.V., founded in 2016 and headquartered in The Hague, Netherlands, specializes in the installation of offshore wind turbine foundations. The company has developed an innovative technique known as the GBM Vibro-drill, which allows for the silent installation of these foundations. This method aims to minimize ocean noise and its impact on marine ecosystems and nearby communities, thereby facilitating the growth of the renewable energy sector's offshore operations. GBM Works combines conventional installation techniques with advanced technology to enhance the efficiency and sustainability of offshore wind energy projects.

FibriTech specializes in the development of advanced 3D fibrous network materials with a range of applications across various industries. The company focuses on creating innovative technologies that provide sustainable alternatives to conventional materials such as Styrofoam, rock wool, and foamed plastics. Their offerings include products and services in agritech, packaging, filters, insulators, ecomaterials, hydroponics, and biocomposites, emphasizing lightness and strength in their biomaterials. FibriTech's solutions aim to meet the growing demand for environmentally friendly materials, supporting clients in reducing their reliance on problematic spatial materials.

Acorai is a medical device company focused on developing a non-invasive heart failure monitoring platform that centers around direct intracardiac pressure monitoring (ICPM). The company utilizes a unique combination of sensor technologies and machine learning to enable accurate and cost-effective heart failure management. Acorai's technology allows for the non-invasive monitoring of cardiac and pulmonary pressure through the analysis of acoustic, vibratory, and waveform data, making it the only proven method to enhance outcomes for heart failure patients. The device has received clinical validation and has been designated as an FDA Breakthrough Device, with plans to enter the market in 2025. By enabling healthcare professionals to proactively adjust medications, Acorai aims to reduce both the rates of heart failure re-hospitalization and mortality.

Onward is a medical technology company focused on developing therapies aimed at enabling functional recovery for individuals with spinal cord injuries. The company is creating an Implantable Neuro-stimulation System (INS) that features real-time motion feedback and utilizes training tools for rehabilitation. Onward has developed two platforms for neurostimulation: ARCIM, an implantable system, and ARCEX, a non-invasive transcutaneous system. To establish its customer base, Onward has targeted the United States and four European markets, namely Germany, France, the United Kingdom, and the Netherlands.

AISPECO is a Lithuanian company specializing in geospatial monitoring systems for various vehicles including helicopters, planes, UAVs (unmanned aerial vehicles), and terrestrial vehicles. The company develops aerial inspection systems tailored for conducting powerline surveys using both helicopters and drones. Their platform facilitates the capture of multiple-angle optical, infrared, corona, and hyperspectral imagery, enabling clients to perform efficient infrastructure inspections while optimizing helicopter operations for endurance and scale.

Quantune Technologies is a deep tech startup specializing in optics and photonics technology. The company focuses on developing advanced infrared spectrometers that facilitate continuous and non-invasive health monitoring. By miniaturizing traditional laboratory equipment used for molecular analysis into compact modules, Quantune enables both biomedical consumer devices and industrial applications. This innovation allows clients to efficiently conduct real-time monitoring and analysis of chemical compounds and emissions, providing accessible solutions for a range of novel applications.

Turing College operates as an online educational institution specializing in data science. It offers courses suitable for individuals of varying skill levels and employs an income share agreement model, allowing students to defer payment until they secure employment. The college collaborates with tech companies to co-create its curriculum, providing these partners with real-time student performance updates to facilitate expedited hiring decisions.

Innoventric is a medical device company based in Ness-Ziona, Israel, focused on developing innovative percutaneous solutions for Tricuspid Regurgitation and right heart disease. Founded in 2017, the company has made significant advancements with its proprietary Trillium™ technology, designed to treat Tricuspid Valve Regurgitation. Innoventric's device features a functional tricuspid valve replacement that employs cross-caval anchoring and a multi-valve design, aimed at enhancing blood flow regulation. The company has conducted over ten implantations of the Trillium™ technology as part of its first human clinical trial in Europe. Additionally, Innoventric maintains a comprehensive patent portfolio for the Trillium™ and related technologies, positioning itself as a key player in the structural heart medical device sector.

INBRAIN Neuroelectronics is a medical device company based in Barcelona, Spain, founded in 2019. It specializes in developing graphene-based neural interfaces and intelligent neuromodulation systems aimed at treating brain disorders. The company has created the world's first graphene-based brain-computer interface (BCI) therapeutics platform, which integrates precise BCI decoding with micrometric modulation. This innovative technology allows for real-time monitoring and adaptive, personalized treatments for conditions such as Parkinson's disease, epilepsy, and stroke rehabilitation. By utilizing AI-driven solutions, INBRAIN maximizes therapeutic outcomes while minimizing side effects. The company is also expanding its capabilities through strategic partnerships, including collaborations with Merck KGaA and its subsidiary INNERVIA Bioelectronics, to explore applications in peripheral nerve and systemic diseases, advancing the field of neurotechnology and bioelectronics.

Maynooth University is internationally recognised for quality and value of Their research and scholarship and Their dedication and commitment to teaching and Their students. Part of the NUI and formally established as an autonomous university in 1997, Maynooth University traces its origins to the foundation of the Royal College of St. Patrick in 1795, drawing inspiration from a heritage that includes over 200 years of education and scholarship. The University is a place of lively contrasts. It is a modern institution, dynamic, rapidly-growing, research-led and engaged, yet grounded in historic academic strengths and scholarly traditions.

Hideez is a cybersecurity company that specializes in manufacturing hardware for secure authentication and access control. Based in the USA and Ukraine, the company offers the Hideez Key, a hybrid device that combines wireless authentication, password management, and digital signature capabilities. Utilizing encrypted Bluetooth, RFID, and NFC technologies, the Hideez Key provides a secure, adaptable, and convenient solution for both physical and logical access. It complements existing market solutions and is designed to be platform-agnostic, supporting a wide range of authentication standards.

Sequentia Biotech, founded in 2013 by Walter Sanseverino and Riccardo Aiese Cigliano, is a bioinformatics company based at the UAB Research Park. The company specializes in transforming genomic data into actionable knowledge for various sectors including academic research, plant and animal breeding, and biomedicine. Sequentia serves a diverse client base of over 30 public and private research centers, companies, and hospitals, participating in more than 160 R&D projects. The company offers cloud software, custom software, and bioinformatics consulting services, with notable contributions such as two open-source biodata banks and an award-winning R&D line called Tricopharming, established in 2014. Sanseverino and Aiese have published over 40 scientific articles in high-impact journals, underscoring the company's expertise in omics sciences.

Ephos specializes in manufacturing high-performance integrated photonic circuits using proprietary glass technology. Its products minimize signal loss, facilitating innovative designs for classical and quantum computing applications, as well as quantum communications and sensing. Ephos caters to the computational infrastructure sector, offering tailored, high-quality solutions.

Reverion specializes in the development of innovative, reversible, carbon-negative power plants that harness biogas through patented technology. The company’s containerized units are designed for mass manufacturing and achieve remarkable electrical efficiencies of 80% for both power generation and energy storage. By effectively doubling the electricity output of traditional gas engines, Reverion’s technology not only enhances the performance of existing biogas plants but also mitigates greenhouse gas emissions, resulting in a negative CO2 balance. In addition to generating renewable energy, Reverion’s solutions utilize excess solar and wind power, thereby contributing to grid stability and promoting a renewable and decarbonized future.

Treble Technologies is a company that focuses on advanced wave-based sound simulation products tailored for the architecture, engineering, and construction (AEC) industry. It offers specialized acoustics design software that enables the creation of physically accurate and perceptually realistic virtual acoustics. This software aids in minimizing risks and ensuring that designs adhere to all relevant regulations and certification standards. Additionally, it streamlines the process of importing, exporting, and reconfiguring models, ultimately saving time and costs for users. Treble's services find applications across various sectors, including automotive design, building architecture, immersive reality, and artificial intelligence, supporting studios and artists in delivering high-quality projects.

Wattalps is a technology company specializing in the development of lithium power systems tailored for small and medium-scale applications. Their product portfolio focuses on affordability, passive safety measures, efficient cooling mechanisms, extended lifespan, and robust cell protection features. Wattalps aims to simplify integration into vehicles or charging stations by offering standard and modular products, thereby facilitating swift, efficient, and cost-effective adoption of electric vehicle technologies and sustainable transportation solutions.

Oryl Photonics specializes in developing laboratory instruments for pharmaceutical and biotech companies. Their core product provides a simple, reliable, and cost-effective method for measuring solubility, contributing to accelerated drug development and improved medicine. The company's unique technology preserves valuable substances during testing, offering a solubility measurement service that empowers researchers to make data-driven decisions and expedite product development.

Onego Bio is a biotechnology company focused on producing animal-free egg white protein through precision fermentation. Their flagship product, Bioalbumen, offers a sustainable alternative to traditional egg proteins, boasting identical taste and nutritional profiles while providing superior functional properties and a significantly reduced environmental footprint. By employing commercially proven technology, Onego Bio meets the growing demand for stable and sustainable functional ingredients within the food industry. The company has gained recognition as a leader in innovation, winning Fast Company’s 2023 World Changing Ideas award. Additionally, Onego Bio is actively involved in the industry as a co-founder of the Precision Fermentation Alliance and Food Fermentation Europe, further establishing its commitment to advancing sustainable food solutions.

Dotlumen is a research startup founded in 2020 and based in Cluj, Romania, focused on enhancing the quality of life for visually impaired individuals. The company develops innovative glasses equipped with a sensory and feedback system that aids users in navigating their environments. By leveraging advancements in artificial intelligence, robotics, and neuroscience, Dotlumen aims to empower blind individuals to better understand and interact with the world around them.

MediWound Ltd. is an integrated biopharmaceutical company based in Yavne, Israel, that specializes in developing, manufacturing, and commercializing innovative therapeutic products for severe burns and chronic wounds. Founded in 2000, the company is known for its flagship product, NexoBrid, which is an FDA-approved biopharmaceutical designed for the removal of eschar in adults with deep partial- and full-thickness thermal burns, offering a less invasive alternative to surgical interventions. MediWound also advances other product candidates, including EscharEx, which has completed Phase II clinical trials for the debridement of chronic and hard-to-heal wounds, and MWPC003 for connective tissue disorders. The company aims to address significant unmet medical needs in these areas and improve patient outcomes.

MediWound Ltd. is an integrated biopharmaceutical company based in Yavne, Israel, that specializes in developing, manufacturing, and commercializing innovative therapeutic products for severe burns and chronic wounds. Founded in 2000, the company is known for its flagship product, NexoBrid, which is an FDA-approved biopharmaceutical designed for the removal of eschar in adults with deep partial- and full-thickness thermal burns, offering a less invasive alternative to surgical interventions. MediWound also advances other product candidates, including EscharEx, which has completed Phase II clinical trials for the debridement of chronic and hard-to-heal wounds, and MWPC003 for connective tissue disorders. The company aims to address significant unmet medical needs in these areas and improve patient outcomes.

Endoron Medical is a company focused on developing innovative medical devices aimed at enhancing the treatment of abdominal aortic aneurysms. The company specializes in creating an endovascular suture and a fixation device for endografts, which are essential for patients undergoing endovascular aneurysm repair. By employing advanced technology, Endoron Medical aims to provide long-lasting sealing solutions that improve patient outcomes and support healthcare professionals in effectively managing this serious condition.

Axelera AI is a company focused on advancing artificial intelligence through its specialized hardware and software platforms, particularly for edge computing applications. Its flagship product, the Metis™ AI Platform, combines innovative hardware and software to offer high-performance and energy-efficient AI inference solutions. Recognized for its innovation, the platform was honored at the CES® 2024 Innovation Awards. Established in 2021, Axelera AI was incubated by Bitfury, a leader in emerging technologies, and partnered with imec, a prominent nano-technology group. The company is headquartered in the AI Innovation Center at the High Tech Campus in Eindhoven, with research and development offices located in Belgium, Switzerland, and Italy. The team consists of experts in AI software and hardware, many of whom have backgrounds with leading AI firms and Fortune 500 companies. Axelera AI’s platform features a unique custom dataflow architecture with multicore in-memory computing, enabling clients to achieve optimal power efficiency while supporting various networks for sustainable edge applications.

Innatera is an innovative company specializing in the development of ultra-low power neuromorphic processors designed to replicate the brain's mechanisms for sensory data processing. Founded in 2018 as a spin-off from the Delft University of Technology, the company focuses on creating advanced analog-mixed signal processing architectures. These neuromorphic chips enable sensor data to be processed significantly faster—up to 100 times quicker—while consuming up to 500 times less energy compared to traditional processors. By leveraging the principles of spiking neurons and synapses, Innatera's technology provides businesses with efficient access to real-time sensor data, enhancing their capabilities in various applications.

UroMems is a medical device company dedicated to addressing specific clinical needs related to urinary conditions that significantly impact patients' quality of life. The company specializes in the design, development, and commercialization of active implantable medical devices. Its innovative approach aims to enhance existing surgical treatments by minimizing associated side effects and ensuring that patients receive appropriate care promptly. Through its commitment to improving treatment options, UroMems seeks to benefit a wide range of patients facing urinary health challenges.

iOnctura is a biopharmaceutical company specializing in the development of novel therapeutics aimed at addressing immunosuppression within the tumor microenvironment, which plays a significant role in cancer progression. The company seeks to enhance existing immune checkpoint therapies by creating new drugs that, when used in conjunction with these therapies, may improve safety and efficacy for cancer patients. iOnctura has formed strategic partnerships with prominent organizations, including Merck and Cancer Research Technology, to advance a pipeline of preclinical molecules toward clinical application. With access to advanced drug discovery labs and a network of academic collaborators, iOnctura is well-equipped to develop innovative combination therapies in the realm of cancer immunology, ultimately striving to optimize treatment outcomes for patients.

Qblox is a Dutch scaleup specializing in quantum technology, focused on developing patented solutions for the scalable control of quantum computers. The company designs and manufactures modular control hardware that simplifies the experimental setups involving qubits, employing a distributed processor architecture to enhance gate fidelities. By advancing electronics with improved noise and drift performance, Qblox enables scientists to minimize crosstalk and achieve low-latency arbitrary control flows while optimizing measurement efficiency in dynamic readout conditions. The company aims to address the scientific and engineering challenges that must be overcome to transition from prototype quantum computers to powerful, practical quantum processors.

Bank of Memories operates a digital platform for long-term preservation of personal data, enabling users to store and organize various forms of digital memories, such as photos, videos, and documents. The platform employs blockchain technology and decentralized storage to ensure data security and longevity, allowing individuals and families to pass on their memories across generations. It offers features like digital monuments for commemorative purposes and a dedicated data room for secure storage, along with an explorer tool for navigating stored information and a whitepaper detailing the platform's technology.

King's College London (informally King's or KCL) is a public research university located in London, United Kingdom, and a constituent college of the federal University of London. King's is arguably the third-oldest university in England, having been founded by King George IV and the Duke of Wellington in 1829, receiving its royal charter in the same year. St Thomas' Hospital, which is now a teaching hospital of King's College London School of Medicine, has roots dating back to 1173. In 1836, King's became one of the two founding colleges of the University of London. King's is based in the centre of London and organised into nine academic schools, spread across four Thames-side campuses in central London and another in Denmark Hill in south London. It is one of the largest centres for graduate and post-graduate medical teaching and biomedical research in Europe; it is home to six Medical Research Council centres for <a href="https://www.dissertationcorp.co.uk/">dissertation help</a> , the most of any British university, and is a founding member of the King's Health Partners academic health sciences centre. King's has around 25,000 students and 6,113 staff and had a total income of £587 million in 2012/13, of which £164 million was from research grants and contracts. King's is a world-leading university, currently ranked 19th in the world (6th in the UK and 8th in Europe) in the 2013 QS World University Rankings, and 38th in the world (6th in the UK and 9th in Europe) in the 2013 Times Higher Education World University Rankings. There are currently 12 Nobel Prize laureates amongst King's alumni and current and former faculty. King's is a member of the Association of Commonwealth Universities, the European University Association, the Russell Group and Universities UK. It forms part of the 'golden triangle' of British universities.

Tilkal is a Paris-based company founded in 2017 that specializes in supply chain traceability and trust solutions for Industry 4.0. The company has developed a software infrastructure that organizes traceability data across various supply chain stakeholders, utilizing a unique B2B blockchain network to facilitate secure and verifiable data sharing. Tilkal's platform incorporates analytics and scoring algorithms to provide an end-to-end, real-time representation of supply chains. This enables businesses to address critical questions regarding product location, sourcing risks, ESG commitments, and compliance verification. Prominent clients include Danone, Daher, Joone, and the NGO Responsible Mica Initiative, which leverage Tilkal's capabilities for diverse applications such as tracing infant milk sourcing and analyzing mica supply chains. The Tilkal network comprises over 70 independent nodes and serves nearly 700 companies, reinforcing its role in promoting resilience, sustainability, and ethical practices within supply chains.

ProFuse Technology is a developer of advanced cultured meat production technology aimed at transforming traditional meat production methods. The company focuses on enhancing the efficiency of meat production by significantly reducing production time, improving the quality of the meat, and increasing overall yields. By accelerating muscle fiber growth, ProFuse's innovative technology enables meat producers to optimize their processes, leading to cost reductions and increased production capacity. This approach positions ProFuse Technology at the forefront of the cultured meat industry, addressing the growing demand for sustainable and high-quality meat alternatives.

Riverlane is a developer of quantum computing software focused on transforming experimental technology into commercial products. The company engineers innovative instruments in collaboration with quantum computer manufacturers, addressing the need for new hardware and software tools to manage the instability of qubits and rectify system defects at unprecedented speeds. Riverlane's software includes an ultra-low latency quantum operating system that accelerates quantum-classical hybrid algorithms, supporting hardware research and development. Additionally, the company creates algorithms designed to optimize the use of the entire quantum computing stack, assisting hardware partners in minimizing the system errors that currently challenge quantum computing capabilities.

Vitestro is a developer of innovative medical robotic devices focused on enhancing patient care through autonomous blood drawing technology. The company's flagship device employs multi-dimensional ultrasound detection to identify nerves and arteries, utilizing deep learning algorithms to minimize the risk of arterial complications during clinical procedures. This advancement aims to streamline the blood collection process in hospitals and clinical laboratories, ultimately enabling healthcare professionals to perform operations with greater precision and improve overall patient health outcomes.

Vitestro is a developer of innovative medical robotic devices focused on enhancing patient care through autonomous blood drawing technology. The company's flagship device employs multi-dimensional ultrasound detection to identify nerves and arteries, utilizing deep learning algorithms to minimize the risk of arterial complications during clinical procedures. This advancement aims to streamline the blood collection process in hospitals and clinical laboratories, ultimately enabling healthcare professionals to perform operations with greater precision and improve overall patient health outcomes.

3Deus Dynamics is a pioneering company specializing in advanced three-dimensional printing solutions. It has developed an innovative hybrid technology that combines elements of 3D printing and traditional injection molding, allowing for the processing of a wide range of polymers without the need for chemical reformulation. This technology eliminates the requirement for support structures and overcomes design geometry limitations, enabling the creation of complex products. The company's dynamic modeling capabilities enhance its manufacturing process by simulating composite materials, which facilitates the production of items tailored to specific functional properties. As a result, 3Deus Dynamics offers clients the flexibility to print a diverse array of products on demand, positioning itself at the forefront of the 3D printing industry.

Basemark Oy is a technology company based in Espoo, Finland, specializing in performance measurement and augmented reality software for various industries, particularly in automotive applications. Founded in 2015, Basemark develops a suite of benchmarking tools that include Basemark ES 3.1 for graphics performance comparisons, Basemark OS II for system-level performance assessment of smartphones and tablets across multiple platforms, and Basemark X for evaluating gaming and graphics performance. Additionally, it offers Browsermark, which tests browser performance on a range of devices, and Basemark CL for measuring OpenCL implementations. In the automotive sector, Basemark provides a comprehensive suite of augmented reality development tools, enabling original equipment manufacturers and suppliers to create and deploy advanced AR applications for vehicle functions. These tools encompass features such as augmented reality navigation, head-up displays, and AI-based spatial computing, enhancing safety and performance in software-defined vehicles.

BOYDSense is a medical device company founded in 2015 and headquartered in South San Francisco, California. The company specializes in developing non-invasive and affordable tools for measuring critical biomarkers through exhaled breath. BOYDSense focuses on breath-based metabolomics, which involves capturing, identifying, and quantifying volatile organic compound (VOC) biomarker patterns found in human breath. This innovative approach enables medical professionals to simplify the monitoring, screening, and risk stratification of chronic diseases, facilitating more effective diagnosis and ongoing management of these conditions.

E-peas SA is a Belgian company established in 2014, specializing in the design and manufacturing of electronic systems that provide energy autonomy for Internet of Things (IoT) applications. The company develops innovative energy harvesting solutions that enable devices to draw energy from various ambient sources, including solar, thermal, vibration, and radiofrequency. E-peas produces energy harvesting power management integrated circuits (PMICs) and microcontrollers that enhance the performance and longevity of IoT devices by either extending battery life or eliminating the need for batteries altogether. Their technology caters to a wide range of sectors, including home automation, healthcare, retail, and agriculture, thereby facilitating the creation of smarter and more energy-efficient connected devices. Headquartered in Mont-Saint-Guibert, Belgium, E-peas aims to transform the landscape of portable energy solutions.

Dronamics is a developer of advanced unmanned aerial systems aimed at transforming airfreight logistics. By creating a new type of small, unmanned cargo airplane that is highly fuel-efficient, Dronamics aims to democratize shipping in emerging markets. The aircraft can transport payloads of 350 kilograms over distances of 2,500 kilometers at costs significantly lower than traditional air transport, reducing shipping expenses by over 50%. Designed for autonomous flight, the aircraft can be remotely monitored and managed via satellite, making it suitable for challenging delivery scenarios, including remote and mountainous regions. As the first and only Strategic Partner for drones recognized by IATA, Dronamics is positioned to make a substantial impact in the commercial logistics sector.

RS Research is a clinical-stage biotechnology company based in Istanbul, Turkey, focused on developing innovative nanomedicines for cancer treatment. Founded in 2015, the company has established a proprietary drug delivery platform known as Sagitta®, which enhances the therapeutic index of its drug candidates. RS Research’s pipeline includes multiple proprietary programs at various stages of preclinical and clinical development, with its lead candidate, RS-0139, currently undergoing Phase I clinical trials in oncology patients. The company also offers a range of services, including preclinical absorption and metabolism assessments, bioanalytical testing, and patent consulting. Additionally, RS Research operates a GMP-certified production facility for the manufacture of clinical batch drug candidates and actively engages in co-development projects with international partners.

Ability Pharmaceuticals is a drug discovery and development company based in Barcelona, Spain. It develops human therapeutics targeting cell membranes to treat cancer and other indications with unmet medical needs. Ability Pharmaceuticals is focused on developing new drugs for the treatment of lung cancer and pancreatic cancer. The company develops Lipid Analogue Therapeutics, a new drug class that modifies the composition of the cell membrane and displays a capacity to influence the local organization of lipid structures in the cell membrane, inducing the formation of non-lamellar phase structures. Its development pipeline includes ABTL0812 product in preclinical development; and ABTL1014, a drug candidate in preclinical characterization.

Multiverse Computing SL is a software development company based in San Sebastian, Spain, with an additional office in Toronto, Canada. Established in 2019, the company specializes in creating quantum computing software that leverages probabilistic and nondeterministic technologies to address complex challenges in various sectors, particularly finance. Multiverse Computing's software solutions are designed for portfolio optimization, risk analysis, and market simulation, enabling clients in industries such as banking, energy, manufacturing, and logistics to harness the power of quantum computing. By focusing on these tailored applications, the company aims to facilitate advancements in solving financial and macro-economic problems, positioning itself as a key player in the emerging quantum technology landscape.

Smart Farm Robotix specializes in manufacturing agricultural robots that tackle the challenges of manual weeding, herbicide use, and machine weeding. Their robots provide a cost-effective, reliable, and fully automated solution, equipped with innovative weed detection and elimination technology. This enables farmers to cultivate crops more efficiently and sustainably, while reducing dependence on manual labor and harmful chemicals.

FreezeM is a company focused on advancing the use of insects as a sustainable protein source for the animal feed industry. Recognizing the potential of insects to address the growing demand for alternative protein, FreezeM develops innovative preservation technologies that facilitate large-scale freezing of insect species. This process aims to create a reliable supply of ready-to-use suspended neonates and frozen eggs, akin to agricultural seed production, which can overcome challenges related to availability, cost, and regulatory constraints. By establishing global stocks of beneficial insects, FreezeM supports various applications, including protein for animal feed, biological pest control, and species preservation, ultimately contributing to a more sustainable food system.

Daze is an engineering startup focused on creating innovative solutions for electric vehicle charging. Its flagship product, DazePlug, is an automatic charging device that utilizes smart charging ecosystems and energy management systems. This technology enables automatic inductive charging, significantly reducing the time required to charge electric vehicles while eliminating the need for manual handling of cables. DazePlug features a retrofit design that is both waterproof and dustproof, ensuring durability and ease of use. By simplifying the charging process, Daze aims to enhance user experience and convenience for electric vehicle owners.

Palobiofarma is a Spanish biotechnology company based in Barcelona’s Science Park, dedicated to discovering and developing innovative drugs that target adenosine receptors. The company aims to be the first European entity to bring an adenosine modulator to market, focusing on the treatment of diseases such as advanced prostate cancer. Through its expertise in medicinal chemistry and in vitro pharmacology, Palobiofarma is committed to advancing the understanding of adenosine's role in disease and enabling healthcare professionals to improve patient outcomes through novel therapeutic options.

Heart Aerospace AB, established in 2018 with headquarters in Gothenburg, Sweden, and operations in Palo Alto, California, specializes in developing electric regional airliners certified for passenger flight. The company's mission is to facilitate swift, affordable, and sustainable travel for regional journeys worldwide. Their flagship aircraft, the ES-19, is a nineteen-passenger electric airliner designed with an operating range of 400 km, aiming to reduce fuel and maintenance costs compared to traditional aircraft while emitting zero operational emissions. Heart Aerospace targets commercial operation certification for the ES-19 by 2026.

Infinite Roots is a technology-driven company focused on creating sustainable health and wellness products using natural ingredients. The company specializes in fermentation technology, particularly the cultivation of mushroom mycelium, to produce healthy and eco-friendly foods. Their product range includes herbal supplements, skincare solutions, and meat alternatives, all designed to support holistic well-being and environmental sustainability. Infinite Roots is committed to using organic and ethically sourced materials, blending traditional remedies with modern science to promote natural healing and balance.

Brite Solar is a nanomaterials company focused on developing advanced transparent solar glass technology for greenhouse and building applications. By utilizing innovative materials and deposition techniques, Brite Solar has created glass that not only generates electricity but also enhances energy efficiency in buildings by reducing the energy required for heating, cooling, and lighting. Its primary market involves the creation of solar glass for greenhouses, which enables these structures to produce their own electricity, significantly lowering energy costs and minimizing reliance on external power sources. This self-sufficient technology can reduce operational costs for greenhouse operators by up to 28%, while also contributing to a negative carbon footprint in crop production. Additionally, Brite Solar's technology is adaptable for future applications, including auto-dimming glass and architectural glass solutions for construction.

Aldoria specializes in space situational awareness, focusing on the collection, processing, and utilization of data to protect vital assets in orbit. The company addresses the growing challenges of space sustainability caused by increasing space debris and traffic. Aldoria's services encompass the detection, tracking, and cataloging of artificial satellites and space debris, as well as assessing collision risks. By providing a new-generation platform for space situational awareness and comprehensive sustainability reports, Aldoria empowers operators and space organizations to navigate safely and effectively, helping them avoid potential hazards and make informed decisions regarding orbital maneuvers.

QphoX specializes in developing quantum modem devices that facilitate connections between quantum computers over a network. Their technology focuses on creating a quantum transducer that couples microwave and optical photons through a mechanical intermediary resonator. This process converts information between microwave domain and optical telecom frequencies, enhancing the fidelity and reducing loss during the transmission of quantum states.

Wavess is an innovative predictive marketing analytics platform that utilizes advanced artificial intelligence technologies to assist businesses in anticipating the success of their marketing campaigns prior to launch. The platform integrates sophisticated AI algorithms with behavioral science to deliver personalized recommendations that improve engagement and conversion rates. Targeting digital marketing agencies, scale-ups, and enterprises within the fintech, retail, and technology sectors, Wavess offers critical insights into audience preferences and effective customer segmentation. Its unique features, such as pre-launch prediction and ideal customer profiling, empower users to optimize campaign outcomes and develop tailored marketing strategies. Additionally, Wavess analyzes audience demographics and campaign trends to create personalized posting schedules, enhancing overall campaign performance.

Sentante is a medical technology company specialising in the development of robotic teleoperated systems for endovascular procedures. Their core product enables physicians to perform complex surgeries remotely, reducing their exposure to harmful X-rays and expanding telesurgery capabilities.

NETRIS Pharma S.A.S. is a biotechnology company based in Lyon, France, focused on the identification and development of therapeutic molecules aimed at treating various forms of cancer. Established in 2008, the company specializes in targeting dependence receptors, which are trans-membrane proteins that play a crucial role in cellular signaling and tumor control. NETRIS Pharma conducts both in vitro and in vivo research, as well as preclinical practices, to manufacture drugs specifically for the treatment of breast cancer, lung cancer, glioblastoma, and neuroblastoma. Through its innovative approach, the company aims to advance cancer therapies and contribute to improved patient outcomes in the pharmaceutical industry.

Lotus Microsystems offers miniaturized highly integrated point of load power converters. The devices are engineered for portable electronics manufacturers ready for usage whenever tiny power supply units are needed. Our devices offer up to 72% reduction in footprint compared to existing solutions with higher efficiency and reliability. Our plug and play solutions enable our customers to innovate their electronics without worrying about power supply units.

Antabio is a private biopharmaceutical company based in Labege, France, focused on developing innovative treatments for drug-resistant infections, particularly targeting critical priority pathogens. Founded in 2009, the company specializes in creating novel antibacterial resistance-breakers, including stand-alone inhibitors of bacterial metalloenzymes. These inhibitors are designed to be combined with existing antibiotics, such as carbapenems, to restore their efficacy against the most challenging pathogens responsible for life-threatening infections, including carbapenem-resistant nosocomial pneumonia. Antabio aims to address significant unmet medical needs in the treatment of drug-resistant infections, ultimately providing healthcare professionals with effective medicinal products to combat these critical health challenges. The company has been recognized for its work, receiving a Wellcome Trust Seeding Drug Discovery Award.

Ignion is an antenna innovator based in Sant Cugat del Vallès, Spain, founded in 2015. The company specializes in the manufacturing of multiband, multipurpose antennas designed to address mobile and wireless connectivity needs. Ignion provides off-the-shelf antennas that cater to the Internet of Things and short-range wireless devices, particularly suited for indoor environments. Their products are designed for easy and efficient integration into industrial designs, enabling clients to meet their connectivity requirements effectively.

Quantum Diamonds specializes in the development of nitrogen-vacancy (NV) diamonds for quantum sensing applications. The company designs advanced quantum sensors capable of measuring magnetic fields, temperature, and pressure, offering enhanced sensitivity and resolution compared to traditional sensors. These sensors enable a range of applications, including navigation, bio-imaging, geographical surveying, and spectroscopy, even under challenging conditions. Quantum Diamonds focuses on optimizing performance in areas such as crystal lattice strain, Rabi contrast, and charge state stability, catering to both industrial and academic customers seeking innovative solutions in quantum mechanics.

RespiQ is a healthtech startup focused on developing portable, non-invasive breath analysis technology for the early detection and management of respiratory diseases. The company employs advanced emission spectroscopy and artificial intelligence to identify volatile organic compounds in breath, facilitating real-time detection of conditions such as COPD exacerbations. RespiQ emphasizes affordability, portability, and user-friendliness to democratize access to advanced diagnostics, thereby enhancing patient outcomes and reducing healthcare costs. In addition to its primary focus on respiratory diseases, RespiQ's versatile platform technology has potential applications for conditions such as asthma, lung cancer, and infectious diseases. The company also offers an intuitive app that provides personalized health insights, allowing users to monitor changes in their health and make informed dietary choices, ultimately empowering individuals to improve their overall well-being.

Efenco is a cleantech startup focused on enhancing the energy conversion efficiency of industrial furnaces and boilers while minimizing their carbon emissions. The company has developed a patented high-energy ray ceramic chip (HERC) that significantly reduces CO2 emissions and fuel costs by at least 18% in energy-intensive sectors, including electricity generation, steel manufacturing, pulp and paper production, ceramics, cement, and district heating. By leveraging principles from quantum and plasma physics, nanotechnology, and electrochemistry, Efenco's innovative technology captures and converts waste heat generated during natural gas combustion into a flux of ionizing radiation, thereby enabling industries to optimize energy usage and improve thermal conversion efficiency.

Methinks is a developer of a medical imaging platform that leverages advanced artificial intelligence techniques to enhance the diagnosis of brain-related diseases, particularly acute stroke. Utilizing Google's deep learning framework, Tensorflow, Methinks analyzes neuroimaging data to facilitate accurate and timely diagnoses. The platform offers a significant advantage by enabling stroke assessments through non-contrast CT scans, thereby eliminating the need for contrast CT and reducing the time required for treatment. This innovative approach enhances communication between radiologists, hospitals, stroke units, and other healthcare professionals, ultimately aiming to improve clinical outcomes in stroke care.

NEOGAP Therapeutics is a clinical-stage biopharmaceutical startup focused on immuno oncology. Their pharmaceutical product, personalized tumor trained lymphocytes, offers even one customized cell treatment that is meant to precisely target and destroy cancer in a tailored environment, with very minor side effects.

Acorai is a medical device company focused on developing a non-invasive heart failure monitoring platform that centers around direct intracardiac pressure monitoring (ICPM). The company utilizes a unique combination of sensor technologies and machine learning to enable accurate and cost-effective heart failure management. Acorai's technology allows for the non-invasive monitoring of cardiac and pulmonary pressure through the analysis of acoustic, vibratory, and waveform data, making it the only proven method to enhance outcomes for heart failure patients. The device has received clinical validation and has been designated as an FDA Breakthrough Device, with plans to enter the market in 2025. By enabling healthcare professionals to proactively adjust medications, Acorai aims to reduce both the rates of heart failure re-hospitalization and mortality.

Skytree is a company focused on developing innovative solutions for carbon dioxide capture and recycling. Founded in 2014, it leverages over a decade of research originally aimed at addressing CO2 challenges for astronauts on the International Space Station. Skytree specializes in direct air capture (DAC) technology that efficiently extracts carbon dioxide from ambient air. This technology supports a circular carbon supply, enabling businesses that need CO2 for their operations to reduce reliance on fossil fuels. By providing a reliable source of usable carbon dioxide, Skytree contributes to the transition toward a more sustainable future and a healthier planet. The company boasts a diverse team of skilled scientists, engineers, and business professionals, all guided by an experienced management team.

Quandela is a company focused on advancing quantum computing technology, specifically in the realms of communication networks and optical computers. It specializes in manufacturing photonic quantum computers, which it supplies to industrial clients. A key innovation from Quandela is its single-photon source device, which integrates photonics with semiconductor quantum dots. This device enables the efficient collection of emitted single photons at high rates, significantly reducing charge noise decoherence and facilitating the emission of identical photons with high fidelity. Such capabilities are essential for the development of advanced quantum applications in communication, computation, and sensing, positioning Quandela as a pivotal player in the quantum technology landscape.

RAIKU is a cleantech startup that produces 100% natural packaging material that has also great looks and shock absorption - most importantly, it gives 15-20 times more volume to its raw material making it one of the most resource efficient material uses in the world with high margins. Both the production is and products are clean making no harm to nature. RAIKU has raised over 1.2mln€ in the pre-seed stage, built a team of over 10 people, its own IP and clients are already using its packaging material. This material will up-end the 1 trillion € packaging sector.

ResoTher Pharma is a privately held biotechnology company based in Copenhagen, Denmark. The company specializes in developing peptide-based drugs derived from Annexin A1, an endogenous immunomodulator. These drugs are designed as resolution therapies for diseases where neutrophil-driven inflammation is a key pathological factor. ResoTher Pharma's primary focus is on addressing cardiovascular and inflammatory disorders that have significant unmet medical needs. Their patented peptide drugs target a G-protein coupled receptor expressed on leukocytes, aiming to mimic the body's natural response to resolving inflammation and promoting tissue repair.

SolasCure Limited is a biotechnology company based in Wales, United Kingdom, focused on advancing treatment options for patients with chronic wounds. Founded in 2017, the company is developing Aurase, a hydrogel designed to enhance wound bed preparation through the application of a recombinant enzyme derived from maggots. This innovative approach aims to facilitate wound debridement, a crucial therapeutic procedure that removes dead, damaged, or infected tissue, thereby accelerating the healing process. By leveraging biomimicry and evidence-based medicine, SolasCure seeks to improve patient outcomes across various healthcare settings.

VSORA is an intellectual property provider based in France, specializing in digital signal processing (DSP) technology for semiconductor chips used in advanced digital communications systems, including 5G networks. Founded in 2015 by a team of experienced DSP engineers, the company offers a powerful multi-core DSP architecture that eliminates the need for DSP co-processors, allowing for greater flexibility akin to software programming. VSORA's innovative DSP development flow facilitates collaboration between signal processing and software engineers, significantly accelerating time-to-market for new products. The company focuses on enhancing DSP computing power while optimizing power consumption and performance, ultimately reducing the silicon footprint required for complex integrated circuits.